Medical/Pharmaceuticals
EAN Congress 2022: COVID-19 positive patients at higher risk of developing neurodegenerative disorders, new study shows
COVID-19 positive outpatients are at an increased risk of neurodegenerative disorders compared with individuals who tested negative for the virus, a new study presented today at the 8th European Academy of Neurology (EAN) Congress has shown. VIENNA, June 25, 2022 /PRNewswire/ -- The study, which...
Stryker's debut at World Intelligence Congress: Bringing Stryker's Advanced Digital Healthcare to China
SHANGHAI, June 24, 2022 /PRNewswire/ -- Stryker (NYSE:SYK), a leading medical technologies company, attended the 6th World Intelligence Congress (WIC) in China, showcasing how its Advanced Digital Healthcare solutions brings clinical, operational and financial values for the healthcare market. Th...
Daewoong Pharmaceutical begins multinational phase 2 clinical trial for DWN12088, a new drug for idiopathic pulmonary fibrosis
- U.S. Food and Drug Administration (FDA) approved the IND for the phase 2 clinical trial for patients with idiopathic pulmonary fibrosis - Daewoong Pharmaceutical to start a multinational phase 2 clinical trial for DWN12088 in September SEOUL, South Korea, June 24, 2022 /PRNewswire/ -- Daewoong...
WhaleTeq: Widespread as AEDs Are, Have These Life-Saving Machines Really Come in Handy?
TAIPEI, June 24, 2022 /PRNewswire/ -- Unlike most products, AEDs sit idle most of the time. However, a life-or-death situation follows when it's being used. The consequences can be tragic if an AED isn't properly maintained. WhaleTeq, a professional medical device test solution provider proposed ...
Novavax COVID-19 Vaccine Nuvaxovid™ Recommended for Expanded Conditional Marketing Authorization in the European Union by CHMP for Adolescents Aged 12 Through 17
* Upon authorization, Nuvaxovid™ would be the first protein-based option for adolescents aged 12 through 17 inEurope * Nuvaxovid™ demonstrated 80% efficacy and was generally well-tolerated in adolescents GAITHERSBURG, Md., June 24, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechn...
Use of BioMAP Platform to Assess Nutraceuticals Published in BioMed Central
ST. CHARLES, Mo., June 24, 2022 /PRNewswire/ -- Eurofins Discovery, the leading brand with over 35 years of success providing a complete solution of products and services for drug discovery, announces a client publication advancing cognitive health research through use of the company's BioMAP...
MGI Wins Company Innovation of the Year at 2022 Globee® Awards for Advanced COVID-19 Response Efforts
SHENZHEN, China, June 24, 2022 /PRNewswire/ -- MGI, a company committed to being a world-leading life science innovator, has been awarded a Silver Globee® in the 14th Annual 2022 Golden Bridge Business and Innovation Awards® for its innovative COVID-19 pandemic control and response efforts worldw...
Alterity Therapeutics Announces Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial in Italy
MELBOURNE, Australia and SAN FRANCISCO, June 23, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that the Italian Medicin...
Berry Oncology launches HIFI Pan-Cancer Screening, a multi-cancer early screening product for detecting six high-risk cancers at one time
BEIJING, June 23, 2022 /PRNewswire/ -- On June 23, Berry Oncology, a global leading company specialized in genomic testing and early cancer screening, announced the launch of its innovative one-time precision product HIFI Pan-Cancer Screening, which is an early multi-cancer screening product ...
Merck Opens €59 Million CDMO Facility to Address Demand for Critical Cancer Therapies
* Expansion doubles production of the most highly potent active pharmaceutical ingredients (HPAPIs) * Merck now one of industry's largest manufacturers of these components globally * Builds on company's 30 years' CDMO experience with multi-step, complex, and highly potent compounds DARMSTAD...
I-Mab Receives Top Rankings in Five Categories by Institutional Investor
GAITHERSBURG, Md. and SHANGHAI, June 23, 2022 /PRNewswire/ -- I-Mab ("I-Mab" or the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that it was ranked among the top companies i...
Fosun International's FTSE Russell ESG Rating Upgraded and Becomes First-time Constituent of FTSE4Good Index Series
HONG KONG, June 23, 2022 /PRNewswire/ -- The world's leading index company, FTSE Russell, recently announced the latest ESG (Environmental, Social and Governance) rating results of Fosun International Limited (HKEX stock code: 00656) ("Fosun International"). Fosun International's FTSE Russell ESG...
SCG Cell Therapy Presents Clinical Proof-of-Concept Data at International Liver Congress (ILC) 2022 Annual Meeting
* Clinical trial interim results of SCG101 shows tumour control with lesion shrinkage observed in two out of three patients with advanced HBV-related HCC * Results show rapid and significant serum HBsAg reduction indicates signal of antiviral activity * Data presented support the advancement...
How Can Digitalization of Medical Devices Boost Productivity in Med-tech
The digital transformation of medical devices encourages medtech players to deliver significant value for providers and patients, says Frost & Sullivan. SAN ANTONIO, June 23, 2022 /PRNewswire/ -- The global medical devices industry is undergoing a major transformation in business models, technolo...
Ocumension OT-401 (Product name: YUTIO), a treatment for chronic non-infectious uveitis officially approved for marketing by the National Medical Products Administration
BEIJING, June 23, 2022 /PRNewswire/ -- Ocumension Therapeutics (1477.HK)announced that the New Drug Application (NDA) for the core product in its pipeline, OT-401 (Sterile non-bioerodible intravitreal implant, Product name: YUTIO), was officially approved by the National Pharmaceutical Administ...
A Painless, Micro Injection that One Can Do Oneself with the Latest Chula's Innovation "Detachable and Dissolvable Microneedles"
BANGKOK, June 23, 2022 /PRNewswire/ -- A startup under the umbrella of CU Innovation Hub in collaboration with the Chula Faculty of Science has developed an innovative"Detachable and Dissolvable Microneedle" that makes any injections easy and painless for everyone, while also significantly reduci...
GSK Malaysia Launches Their #GiveBack Recycling Campaign for Safe Disposal of Old Inhalers
Reducing greenhouse gas emissions and material waste from harming the environment PETALING JAYA, Malaysia, June 23, 2022 /PRNewswire/ -- GSK Malaysia is committed to its long-term ambition of delivering net zero emissions across all operations by 2030. By striving to reduce its environmental imp...
China Pharma Announces Receipt of Noncompliance Notice from NYSE American
HAIKOU, China, June 22, 2022 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced that onJune 15, 2022, the Company received a letter from NYSE American LLC ("NYSE American" or the "Exchange"...
First American Patient Treated with VenusP-Valve™ Under Compassionate Use
HANGZHOU, China, June 22, 2022 /PRNewswire/ -- VenusP-Valve™, an in-house developed novel medical device of Venus Medtech (Hangzhou) Inc. (2500.HK, hereinafter referred to as "Venus Medtech"), recently completed its first compassionate use atUniversity of Virginia Advanced Cardiac Valve Center in...
2022 Tang Prize Laureates--Six Voices that Provide Stability to the World
TAIPEI, June 22, 2022 /PRNewswire/ -- Since the outbreak of COVID-19, more than 530 million inflections have been reported globally. With the virus still raging in many countries, the world is suffering from supply chain disruptions and decade-high inflation, which has been exacerbated by the ris...
Week's Top Stories
Most Reposted
HLB Customers Can Now Scan & Pay in China with HLB QR Pay
[Picked up by 294 media titles]
2026-10-22 22:35SALMON SECURES $140 MILLION (PHP 8.8 BILLION) TO DOUBLE DOWN ON THE GROWTH OPPORTUNITY IN THE PHILIPPINES
[Picked up by 282 media titles]
2026-10-19 13:18Infobip and Yamaha Power Conversational Customer Engagement in Indonesia's Automotive Sector
[Picked up by 276 media titles]
2026-10-21 15:00TCL Zhonghuan Powers India's Energy Transition with PV Innovations at REI Expo 2026
[Picked up by 272 media titles]
2026-10-23 21:52DayOne Supports NVIDIA DSX POD Reference Design, Advancing Standardized Infrastructure for AI
[Picked up by 271 media titles]
2026-10-22 11:55